This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Lessons From Cystic Fibrosis

Benjamin S. Wilfond, MD; Kathleen Nolan, MD, MSL

JAMA. 1993;270(24):2948-2954.

Abstract
In recognition of the earlier experiences with genetic diagnostic services and in anticipation of a greater potential for genetic testing for presymptomatic disease and disease susceptibility, this article provides an analysis of policy development for cystic fibrosis carrier screening. The deficiencies of relying on an extemporaneous model for health policy development are described. Preferably, an evidentiary model, based on the evaluation of clinical research and incorporating professional and public attention to underlying normative issues, should define the standard of care. Appropriate procedural mechanisms should be established at both state and federal levels to prevent the unnecessary confusion, expense, and personal or social harms likely to result from a completely unrestrained application of developing genetic technologies or continuing ad hoc responses to rapid increases in genetic diagnostic capabilities. A broadly constituted national advisory commission on the ethical, legal, and social implications of the Human Genome Project would provide an important locus for national decision making and may offer an efficient mechanism for implementing the evidentiary model, promoting public involvement at a time when social policy decisions must be made to restructure the health care system to be more sensitive to issues of access, allocation, and costs.

(JAMA. 1993;270:2948-2954)

Author Affiliations
From the Department of Pediatrics, Arizona Bioethics Program, Steele Memorial Children's Research Center, and Respiratory Sciences Center, University of Arizona Health Sciences Center, Tucson (Dr Wilfond) and The Hastings Center, Briarcliff Manor, NY (Dr Nolan).

Footnotes
Reprint requests to Department of Pediatrics, University of Arizona Health Sciences Center, 1501 N Campbell Ave, Tucson, AZ 85724 (Dr Wilfond).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

From Genetics to Genomics: Ethics, Policy, and Parental Decision-making
Wilfond and Ross
J Pediatr Psychol 2009;34:639-647.
ABSTRACT | FULL TEXT  

From Public Health Emergency to Public Health Service: The Implications of Evolving Criteria for Newborn Screening Panels
Grosse et al.
Pediatrics 2006;117:923-929.
FULL TEXT  

The Use of Gene Tests to Detect Hereditary Predisposition to Chronic Disease: Is Cost-Effectiveness Analysis Relevant?
Col
Med Decis Making 2003;23:441-448.
ABSTRACT  

Direct-to-Consumer Advertising of Genetic Testing
Gollust et al.
JAMA 2003;289:46-46.
FULL TEXT  

Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing
Gollust et al.
JAMA 2002;288:1762-1767.
ABSTRACT | FULL TEXT  

Genetics, Nursing, and Public Policy: Setting an International Agenda
Anderson et al.
Policy Politics Nursing Practice 2000;1:245-255.
ABSTRACT  

Commercial predictive testing: the desirability of one overseeing body
Hoedemaekers
J. Med. Ethics 2000;26:282-286.
ABSTRACT | FULL TEXT  

Serving the Family From Birth to the Medical Home. Newborn Screening: A Blueprint for the Future - A Call for a National Agenda on State Newborn Screening Programs
Pediatrics 2000;106:389-422.
FULL TEXT  

Ensuring Accurate Molecular Genetic Testing
McGovern
Clin. Chem. 1998;44:1146-1148.
FULL TEXT  

State-to-State Variations in Newborn Screening Policies
Stoddard and Farrell
Arch Pediatr Adolesc Med 1997;151:561-564.
ABSTRACT  

Genetic Privacy
Gostin
J Law Med Ethics 1995;23:320-330.
 

Generic Consent for Genetic Screening
Wells et al.
NEJM 1994;331:1024-1025.
FULL TEXT  

Generic Consent for Genetic Screening
Elias and Annas
NEJM 1994;330:1611-1613.
FULL TEXT  

Developing the Clinical Application of Genetic Diagnosis: The Role of NIDDK
Fradkin and Gorden
JAMA 1994;271:1240-1240.
ABSTRACT